China (Mainland)
Premiumsupplier
High Quality Top Grade Olaparib CAS 763113-22-0 CAS NO.763113-22-0
- Min.Order: 10 Gram
- Payment Terms: T/T,
- Product Details
Keywords
- Olaparib
- Olaparib powder
- cas 763113-22-0
Quick Details
- ProName: High Quality Top Grade Olaparib CAS 76...
- CasNo: 763113-22-0
- Molecular Formula: C22H30N4O
- Appearance: white powder
- Application: treatment of adult patients with recur...
- DeliveryTime: immediately
- PackAge: aluminum foil bag
- Port: HK, Shanghai, Shenzhen
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: cool and dry place
- Transportation: email: wonda-chem@outlook.com
- LimitNum: 10 Gram
Superiority
1.high quality:
quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.
2.reasonable price:
we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.
3.low moq:
no worry about the low moq, our moq is 1 gram or even lower.
4.good service.
fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.
5. fast shipping and secure courier.
we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.
Details
Product Name: Olaparib
Form: Powder
CAS Number: 763113-22-0
MF: C24H23FN4O3
M.W: 434.469
Brand: Salus
COA: Available
Sample: Available
Shelf Life: 2 Years
Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair. Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy.
|
Product Name: |
Olaparib |
MF: |
C24H23FN4O3 |
|
CAS No.: |
763113-22-0 |
Specification: |
99% |
|
Purity: |
99% |
Origin: |
China |
|
Item |
Specification |
Results |
|
Appearance |
White Powder |
White Powder |
|
Assay |
99.0%--101.0%(Anhydrous substance) |
99.98% |
|
Purity |
≥99.0% |
99.89% |
|
Water |
≤1.0% |
0.1% |
|
Sulphated ash |
≤0.5% |
0.045% |
|
Related substances |
Unspecified impurities for each impurity |
Complies |
|
Heavy Metals |
≤10ppm |
<10ppm |
|
Loss On Drying |
≤2.0% |
0.19% |
|
Microbiological Analysis |
||
|
Total plate count |
≤1000cfu/g |
Complies |
|
Yeast and moulds |
≤100cfu/g |
Complies |
|
E. Coli |
Negative |
Negative |
|
Conclusion |
Conform with specification |
|
Storage |
Store in sealed containers at cool & dry place. |
|
|
Protect from light, moisture and pest infestation. |
|
Shelf Life |
2 years when properly stored |
Olaparib as a maintenance therapy or monotherapy for the treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. On January 12, 2018, FDA expanded the approved use of Olaparib to include chemotherapy-experienced patients with germline breast cancer susceptibility gene (BRCA) mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
